Exercise testing in asymptomatic patients with heterozygous familial hypercholesterolaemia

Coronary Artery Disease

Volumn 15, Issue 8, 2004, Pages 461-465

  Michaelides, Andreas P ^a,b   Fourlas, Christos A ^a   Pitsavos, Christos ^a   Andrikopoulos, George K ^a   Skoumas, Ioannis ^a   Kartalis, Athanasios ^a   Katsaros, Andreas ^a   Stougiannos, Pavlos ^a   Stefanadis, Christodoulos I ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Exercise testing; Fibrinogen; Heterozygous familial hypercholesterolaemia

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; ARTICLE; BIOCHEMISTRY; BLOOD CLOTTING; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EUROPE; EXERCISE TEST; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENDER; GENETIC DISORDER; HEART MUSCLE ISCHEMIA; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; XANTHOMA;

ADULT; EXERCISE; EXERCISE TEST; FEMALE; FIBRINOGEN; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 15744404400     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200412000-00001     Document Type: Article

References (24)

1. Sijbrands EJ, Westendorp RG, Defesche JC, de Meier PH, Smelt AH, Kastelein JJ. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ 2001; 322:1019-1023.
2. Hirobe K, Matsuzawa Y, Ishikawa K, Tarui S, Yamamoto A, Nambu S, et al. Coronary artery disease in heterozygous familial hypercholesterolemia. Atherosclerosis 1982; 44:201-210.
3. Schuster H. National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III). Managing the high-risk patient: therapeutic approaches in 2002. Atherosclerosis 2003; 4(suppl): 15-20.
4. Hausmann D, Johnson JA, Sudhir K, Mullen WL, Friedrich G, Fitzgerald PJ, et al. Angiographically silent atherosclerosis detected by intravascular ultrasonography in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins. J Am Coll Cardiol 1996; 27:1562-1570.
5. Hopkins PN, Stephenson S, Wu LL, Riley WA, Xin Y, Hunt SC. Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. Am J Cardiol 2001; 87:547-553.
6. Descamps OS, Gilbeau JP, Luwaert R, Heller FR. Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia. Eur J Clin Invest 2003; 33:1-9.
7. Durrington PN. Familial hypercholesterolaemia. In: Hyperlipidemia: diagnosis and management. By Paul N. Durrington. 2nd ed. Oxford University Press: Butterworth Heinemann; 1995. pp. 108-139.
8. Mabuchi H, Koizumi J, Shimizu M, Takeda R. Development of coronary heart disease in familial hypercholesterolemia. Circulation 1989; 79:225-232.
9. Mouratidis B, Vaughan-Neil EF, Gilday DL, Ash JM, Cullen-Dean G, McIntyre S, et al. Detection of silent coronary artery disease in adolescents and young adults with familial hypercholesterolaemia by single-photon emission computed tomography thallium 201 scanning. Am J Cardiol 1992; 70:1109-1112.
10. Hopkirk JA, Uhl GS, Hickman JR Jr, Fischer J, Medina A. Discriminant value of clinical and exercise variables in detecting significant coronary artery disease in asymptomatic men. J Am Coll Cardiol 1984; 3:887-894.
11. Hill JS, Hayden MR, Frohlich J, Pritchard PH. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb 1991; 11:290-297.
12. Panagiotakos DB, Pitsavos C, Skoumas J, Chrysohoou C, Toutouza M, Stefanadis CI, et al. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002). Curr Med Res Opin 2003; 19:89-94.
13. Ferrières J, Lambert J, Lussier-Cacan S, Davignon J. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation 1995; 92:290-295.
14. Umans-Eckenhausen MA, Sijbrands EJ, Kastelein JJ, Defesche JC. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 2002; 106:3031-3036.
15. Hegele RA, Connelly PW, Cullen-Dean G, Rose V. Elevated plasma lipoprotein(a) associated with abnormal stress thallium scans in children with familial hypercholesterolemia. Am J Cardiol 1993; 72:402-406.
16. Tonstad S, Joakimsen O, Stensland-Bugge E, Leren TP, Ose L, Russell D, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol 1996; 16:984-991.
17. Sebestjen M, Zegura B, Guzic-Salobir B, Keber I. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia. Wien Klin Wochenschr 2001; 113:113-118.
18. Yanagi K, Yamashita S, Kihara S, Nakamura T, Nozaki S, Nagai Y, et al. Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance. Atherosclerosis 1997; 132:43-51.
19. Wittekoek ME, de Groot E, Prins MH, Trip MD, Buller HR, Kastelein JJ. Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease. Atherosclerosis 1999; 146: 271-279.
20. Lavrencic A, Kosmina B, Keber I, Videcnik V, Keber D. Carotid intima-media thickness in young patients with familial hypercholesterolaemia. Heart 1996; 76:321-325.
21. Bhatnagar D, Morgan J, Siddiq S, Mackness MI, Miller JP, Durrington PN. Outcome of case finding among relatives of patients with heterozygous familial hypercholesterolaemia. BMJ 2000; 321:1-5.
22. Osterspey A, Treis-Muller I, Gunther H, Eggeling T, Siglow C, Gedicke V, et al. Silent ischaemia in asymptomatic 'healthy' individuals with coronary risk factors. Eur Heart J 1988; 9(suppl N):65-69.
23. Lochen ML. The Tromso study: the prevalence of exercise-induced silent myocardial ischaemia and relation to risk factors for coronary heart disease in an apparently healthy population. Eur Heart J 1992; 13:728-731.
24. Descamps OS, de Meester A, Cheron P, Kastelein JJ, Heller FR. Silent ischaemia in familial hypercholesterolemia. Atherosclerosis 2003; 4 (suppl):7-8.